These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37292986)

  • 1. Host microRNA interactions with the SARS-CoV-2 viral genome 3'-untranslated region.
    Frye CJ; Cunningham CL; Mihailescu MR
    bioRxiv; 2023 May; ():. PubMed ID: 37292986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.
    Pierce JB; Simion V; Icli B; Pérez-Cremades D; Cheng HS; Feinberg MW
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33207533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.
    Chan AP; Choi Y; Schork NJ
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33239366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-Protein Interaction Analysis of SARS-CoV-2 5' and 3' Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection.
    Verma R; Saha S; Kumar S; Mani S; Maiti TK; Surjit M
    mSystems; 2021 Aug; 6(4):e0064321. PubMed ID: 34254825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.
    Arisan ED; Dart A; Grant GH; Arisan S; Cuhadaroglu S; Lange S; Uysal-Onganer P
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32512929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs for Virus Pathogenicity and Host Responses, Identified in SARS-CoV-2 Genomes, May Play Roles in Viral-Host Co-Evolution in Putative Zoonotic Host Species.
    Lange S; Arisan ED; Grant GH; Uysal-Onganer P
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33467206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.
    Jiang L; Xiao M; Liao QQ; Zheng L; Li C; Liu Y; Yang B; Ren A; Jiang C; Feng XH
    mSystems; 2023 Aug; 8(4):e0013523. PubMed ID: 37314180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel SARS-CoV-2 Drug Targets by Host MicroRNAs and Transcription Factors Co-regulatory Interaction Network Analysis.
    Sardar R; Satish D; Gupta D
    Front Genet; 2020; 11():571274. PubMed ID: 33173539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of cellular miRNAs in coronavirus-host interplay.
    Nersisyan S; Engibaryan N; Gorbonos A; Kirdey K; Makhonin A; Tonevitsky A
    PeerJ; 2020; 8():e9994. PubMed ID: 32983652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved Genomic Terminals of SARS-CoV-2 as Co-evolving Functional Elements and Potential Therapeutic Targets.
    Chan AP; Choi Y; Schork NJ
    bioRxiv; 2020 Jul; ():. PubMed ID: 32676601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An
    Arisan ED; Dart DA; Grant GH; Dalby A; Kancagi DD; Turan RD; Yurtsever B; Karakus GS; Ovali E; Lange S; Uysal-Onganer P
    ACS Omega; 2022 Oct; 7(42):38003-38014. PubMed ID: 36275122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential therapeutic approaches of microRNAs for COVID-19: Challenges and opportunities.
    Farshbaf A; Mohtasham N; Zare R; Mohajertehran F; Rezaee SA
    J Oral Biol Craniofac Res; 2021; 11(2):132-137. PubMed ID: 33398242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2.
    Park JH; Choi Y; Lim CW; Park JM; Yu SH; Kim Y; Han HJ; Kim CH; Song YS; Kim C; Yu SR; Oh EY; Lee SM; Moon J
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation.
    Siniscalchi C; Di Palo A; Russo A; Potenza N
    Front Genet; 2021; 12():678994. PubMed ID: 34163530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2-Encoded MiRNAs Inhibit Host Type I Interferon Pathway and Mediate Allelic Differential Expression of Susceptible Gene.
    Zhu Y; Zhang Z; Song J; Qian W; Gu X; Yang C; Shen N; Xue F; Tang Y
    Front Immunol; 2021; 12():767726. PubMed ID: 35003084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-COV-2 as potential microRNA sponge in COVID-19 patients.
    Li C; Wang R; Wu A; Yuan T; Song K; Bai Y; Liu X
    BMC Med Genomics; 2022 Apr; 15(Suppl 2):94. PubMed ID: 35461273
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.